Overview

A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
A prospective, randomized, placebo and active comparator controlled study of CP-690,550 in subjects with dry eye.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Cyclosporine
Cyclosporins
Tofacitinib